{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:43:57Z","timestamp":1771641837520,"version":"3.50.1"},"reference-count":245,"publisher":"Elsevier","isbn-type":[{"value":"9780128140291","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/b978-0-12-814029-1.00010-7","type":"book-chapter","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T16:44:44Z","timestamp":1539362684000},"page":"257-295","source":"Crossref","is-referenced-by-count":26,"title":["Nanoparticles as Delivery Systems in Cancer Therapy"],"prefix":"10.1016","author":[{"given":"Andreia","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Alexandra R.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Pedro V.","family":"Baptista","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib1","author":"World Health Organization","year":"2017"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1586\/14737159.2014.965683","article-title":"Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles","volume":"14","author":"Cabral","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","article-title":"Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging","volume":"8","author":"Parveen","year":"2012","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib5","first-page":"5975","article-title":"Update on nanotechnology-based drug delivery systems in cancer treatment","volume":"37","author":"Ho","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib6","series-title":"Application of nanotechnology in drug delivery","first-page":"14","author":"Silva","year":"2014"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tibtech.2008.04.005","article-title":"Multifunctional nanoparticles \u2013 properties and prospects for their use in human medicine","author":"Sanvicens","year":"2008","journal-title":"Trends Biotechnol"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9040046","article-title":"Targeting strategies for the combination treatment of cancer using drug delivery systems","volume":"9","author":"Kydd","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib9","article-title":"Applications of stimuli-responsive nanoscale drug delivery systems in translational research","author":"Gu","year":"2017","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/B978-0-12-814029-1.00010-7_bib10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/mp100228v","article-title":"Nanotheranostics and image-guided drug delivery: current concepts and future directions","volume":"7","author":"Lammers","year":"2010","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nano.2015.08.006","article-title":"Nanomedicine applied to translational oncology: a future perspective on cancer treatment","volume":"12","author":"Bregoli","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.biopha.2016.09.035","article-title":"Cancer nanotheranostics: strategies, promises and impediments","volume":"84","author":"Roy Chowdhury","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drup.2016.06.003","article-title":"Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?","volume":"27","author":"Blau","year":"2016","journal-title":"Drug Resist Updat"},{"issue":"9","key":"10.1016\/B978-0-12-814029-1.00010-7_bib14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.7150\/thno.15335","article-title":"Targeted nanotheranostics for future personalized medicine: recent progress in cancer therapy","volume":"6","author":"Jo","year":"2016","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/B978-0-12-814029-1.00010-7_bib15","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.imlet.2017.07.015","article-title":"Nanoparticles and targeted drug delivery in cancer therapy","volume":"190","author":"Bahrami","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib17","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2147\/DDDT.S142337","article-title":"The new era of nanotechnology, an alternative to change cancer treatment","volume":"11","author":"Jurj","year":"2017","journal-title":"Drug Des Dev Ther"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1039\/C7BM00297A","article-title":"Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy","volume":"5","author":"Shen","year":"2017","journal-title":"Biomater Sci"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1877912304666140304000133","article-title":"Nanoparticle drug delivery systems: recent patents and applications in nanomedicine","volume":"3","author":"Martins","year":"2013","journal-title":"Recent Pat Nanomed"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.urolonc.2007.03.017","article-title":"New frontiers in nanotechnology for cancer treatment","volume":"26","author":"Alexis","year":"2008","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J\u00a0Control Release"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4155\/tde.12.21","article-title":"Size matters: gold nanoparticles in targeted cancer drug delivery","volume":"3","author":"Dreaden","year":"2012","journal-title":"Ther Deliv"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib23","first-page":"751075","article-title":"Noble metal nanoparticles applications in cancer","volume":"2012","author":"Conde","year":"2012","journal-title":"J\u00a0Drug Deliv"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-00477-3_1","article-title":"Passive and active drug targeting: drug delivery to tumors as an example","volume":"197","author":"Torchilin","year":"2010","journal-title":"Handb Exp Pharmacol"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ma10080929","article-title":"Smart carriers and nanohealers: a nanomedical insight on natural polymers","volume":"10","author":"Raveendran","year":"2017","journal-title":"Materials (Basel)"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-814029-1.00010-7_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","article-title":"Polymeric nanoparticles: promising platform for drug delivery","volume":"528","author":"El-Say","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","article-title":"Recent applications of PLGA based nanostructures in drug delivery","volume":"159","author":"Mir","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","article-title":"Biodegradable nanoparticles for drug delivery and targeting","volume":"6","author":"Hans","year":"2002","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0169-409X(02)00045-5","article-title":"Poly (L-glutamic acid) \u2013 anticancer drug conjugates","volume":"54","author":"Li","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2012.12.013","article-title":"Biocompatibility of engineered nanoparticles for drug delivery","volume":"166","author":"Naahidi","year":"2013","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eursup.2005.04.001","article-title":"Eligard: pharmacokinetics, effect on Testosterone and PSA levels and tolerability","volume":"4","author":"Berges","year":"2005","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1634\/theoncologist.12-8-991","article-title":"FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (all)","volume":"12","author":"Dinndorf","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2007.04.017","article-title":"Formulation of Neulasta\u00ae (pegfilgrastim)","volume":"60","author":"Piedmonte","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/B978-0-12-814029-1.00010-7_bib36","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/sj.bjc.6604372","article-title":"Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer","volume":"98","author":"Paz-Ares","year":"2008","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s10637-012-9921-8","article-title":"First-in-human phase 1\/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies","volume":"31","author":"Weis","year":"2013","journal-title":"Investig New Drugs"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157340711795163866","article-title":"CRLX101 (formerly IT-101)\u2013a novel nanopharmaceutical of camptothecin in clinical development","volume":"7","author":"Young","year":"2011","journal-title":"Curr Bioact Compd"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/0008-5472.CAN-15-2951","article-title":"CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF1\u03b1","volume":"77","author":"Tian","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib40","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib41","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib42","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib43","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib44","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib45","doi-asserted-by":"crossref","first-page":"128ra39","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib46","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"13","key":"10.1016\/B978-0-12-814029-1.00010-7_bib48","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.addr.2009.06.004","article-title":"ProLindacTM (AP5346): a review of the development of an HPMA DACH platinum polymer therapeutic","volume":"61","author":"Nowotnik","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00280-001-0417-z","article-title":"A\u00a0phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy","volume":"49","author":"Vis","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib50","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib51","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10637-010-9399-1","article-title":"A\u00a0phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction","volume":"29","author":"Valle","year":"2011","journal-title":"Investig New Drugs"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib52","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib53","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/bjc.2011.6","article-title":"A\u00a0Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours","volume":"104","author":"Plummer","year":"2011","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/B978-0-12-814029-1.00010-7_bib55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6602772","article-title":"Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats","volume":"93","author":"Uchino","year":"2005","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib56","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00280-010-1326-9","article-title":"Pharmacokinetic\/pharmacodynamic analysis of adjuvant pegylated interferon -\u03b12b in patients with resected high-risk melanoma","volume":"67","author":"Daud","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl. 15","key":"10.1016\/B978-0-12-814029-1.00010-7_bib57","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1200\/JCO.2016.34.15_suppl.4017","article-title":"Phase III randomized study of second line ADI-peg 20 (A)\u00a0plus best supportive care versus placebo (P)\u00a0plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)","volume":"34","author":"Abou-Alfa","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib58","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib59","first-page":"1","article-title":"Synthesis of a macromolecular camptothecin conjugate with dual phase drug release","volume":"1","author":"Yurkovetskiy","year":"2017","journal-title":"Mol Pharm"},{"issue":"36","key":"10.1016\/B978-0-12-814029-1.00010-7_bib60","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1200\/JCO.2013.55.0376","article-title":"First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors","volume":"32","author":"Schultheis","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/B978-0-12-814029-1.00010-7_bib61","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S1470-2045(13)70429-7","article-title":"Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study","volume":"14","author":"Awada","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib62","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib63","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib64","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib65","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib66","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib67","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib68","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.colsurfb.2017.01.041","article-title":"Dendrimer-protein interactions versus dendrimer-based nanomedicine","volume":"152","author":"Shcharbin","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib69","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib70","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/1567201813666160713121122","article-title":"Nanoparticles for cancer targeting: current and future directions","volume":"13","author":"Swain","year":"2016","journal-title":"Curr Drug Deliv"},{"issue":"12","key":"10.1016\/B978-0-12-814029-1.00010-7_bib71","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1002\/jbm.a.34642","article-title":"Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy","volume":"101","author":"Mishra","year":"2013","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib72","first-page":"85","article-title":"Nanoparticle-based delivery of RNAi therapeutics","volume":"6","author":"Zhou","year":"2013","journal-title":"Prog Pharm"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib73","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/wnan.37","article-title":"Methotrexate delivery via folate targeted dendrimer-based nanotherapeutic platform","volume":"1","author":"Majoros","year":"2009","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib74","first-page":"9","article-title":"Lipid-based nanoparticles in cancer diagnosis and therapy","volume":"2013","author":"Miller","year":"2013","journal-title":"J\u00a0Drug Deliv"},{"issue":"10","key":"10.1016\/B978-0-12-814029-1.00010-7_bib75","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/1061186X.2012.716845","article-title":"Nanostructured lipid carriers system: recent advances in drug delivery","volume":"20","author":"Iqbal","year":"2012","journal-title":"J\u00a0Drug Target"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib76","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0022-2836(64)80115-7","article-title":"Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope","volume":"8","author":"Bangham","year":"1964","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2017.07.001","article-title":"Beyond liposomes: recent advances on lipid based nanostructures for poorly soluble\/poorly permeable drug delivery","volume":"68","author":"Teixeira","year":"2017","journal-title":"Prog Lipid Res"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib78","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0936-6555(05)80269-9","article-title":"Liposomal doxotubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS","volume":"6","author":"James","year":"1994","journal-title":"Clin Oncol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib79","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/sj.bjc.6600250","article-title":"A\u00a0phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer","volume":"86","author":"Gibbs","year":"2002","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000421-200202000-00012","article-title":"Phase IV study of liposomal Daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma","volume":"25","author":"Rosenthal","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib81","series-title":"FDA approves Vyxeos (daunorubicin and cytarabine) liposome for injection for certain types of poor-prognosis acute myeloid leukemia","author":"Drugs.com","year":"2017"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jfda.2017.02.001","article-title":"Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers","volume":"25","author":"Lin","year":"2017","journal-title":"J\u00a0Food Drug Anal"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-814029-1.00010-7_bib83","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ijpharm.2017.07.039","article-title":"Nano lipid-drug conjugate: an integrated review","volume":"529","author":"Adhikari","year":"2017","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/B978-0-12-814029-1.00010-7_bib84","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/1061186X.2017.1289540","article-title":"Novel nanoparticulate systems for lung cancer therapy: an updated review","volume":"25","author":"Madni","year":"2017","journal-title":"J\u00a0Drug Target"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-814029-1.00010-7_bib85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2016.11.037","article-title":"Microencapsulated SLN: an innovative strategy for pulmonary protein delivery","volume":"516","author":"Gaspar","year":"2017","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib86","first-page":"55","article-title":"Nanotechnology-based inhalation treatments for lung cancer: state of the art","volume":"19","author":"Ahmad","year":"2015","journal-title":"Nanotechnol Sci Appl"},{"issue":"Suppl. 3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib87","first-page":"S663","article-title":"Topical delivery of Withania somnifera crude extracts in niosomes and solid lipid nanoparticles","volume":"13","author":"Chinembiri","year":"2017","journal-title":"Pharmacogn Mag"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib88","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4155\/tde-2017-0075","article-title":"Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery","volume":"8","author":"Kahraman","year":"2017","journal-title":"Ther Deliv"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000481691","article-title":"Development and evaluation of lipid nanoparticles containing natural botanical oil for sun protection: characterization and in\u00a0vitro and in\u00a0vivo human skin permeation and toxicity","volume":"31","author":"Andr\u00e9o-Filho","year":"2017","journal-title":"Skin Pharmacol Physiol"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-814029-1.00010-7_bib90","first-page":"1","article-title":"Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications","volume":"535","author":"Sala","year":"2017","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib91","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmaceutics5010127","article-title":"From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)","volume":"5","author":"G\u00e9ral","year":"2013","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib93","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejpb.2011.10.012","article-title":"A\u00a0novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid- b-treated rats following intranasal administration","volume":"80","author":"Wu","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib94","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/17425247.2013.758631","article-title":"Hyperthermia-induced drug targeting","volume":"10","author":"May","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib95","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3892\/ol.2014.2449","article-title":"A\u00a0dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy","volume":"8","author":"Qin","year":"2014","journal-title":"Oncol Lett"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib96","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.addr.2007.08.044","article-title":"Protein nanoparticles as drug carriers in clinical medicine","volume":"60","author":"Hawkins","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib97","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1155\/2014\/180549","article-title":"Protein nanoparticles as drug delivery carriers for cancer therapy","volume":"2014","author":"Lohcharoenkal","year":"2014","journal-title":"BioMed Res Int"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib98","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","article-title":"Abraxane\u00ae, a novel Cremophor\u00ae-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer","volume":"17","author":"Green","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib99","first-page":"1","article-title":"Paclitaxel nano-delivery systems: a comprehensive review","volume":"4","author":"Ma","year":"2013","journal-title":"J\u00a0Nanomed Nanotechnol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib100","first-page":"123756","article-title":"Denileukin Diftitox (Ontak) as maintenance therapy for peripheral T-cell lymphomas: three cases with sustained remission","volume":"2015","author":"Fuentes","year":"2015","journal-title":"Case Rep Oncol Med"},{"issue":"23","key":"10.1016\/B978-0-12-814029-1.00010-7_bib101","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1002\/adma.201205292","article-title":"In\u00a0vivo bio-safety evaluations and diagnostic\/therapeutic applications of chemically designed mesoporous silica nanoparticles","volume":"25","author":"Chen","year":"2013","journal-title":"Adv Mater"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib102","first-page":"24","article-title":"Nanophase ceramics for improved drug delivery: current opportunities and challenges","volume":"89","author":"Yang","year":"2010","journal-title":"Am Ceram Soc Bull"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib103","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/ja0343095","article-title":"Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug \u2013 Carrier system for photodynamic therapy","volume":"125","author":"Roy","year":"2003","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700306","article-title":"Synthesis, functionalization, and design of magnetic nanoparticles for theranostic applications","author":"Mosayebi","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2017.09.006","article-title":"Exploiting homing abilities of cell carriers: targeted delivery of nanoparticles for cancer therapy","volume":"145","author":"Tiet","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib106","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11671-008-9174-9","article-title":"Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies","volume":"3","author":"Wu","year":"2008","journal-title":"Nanoscale Res Lett"},{"issue":"9","key":"10.1016\/B978-0-12-814029-1.00010-7_bib107","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.3390\/nano7090243","article-title":"Magnetic nanoparticles: from design and synthesis to real world applications","volume":"7","author":"Kudr","year":"2017","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib108","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/nnm.14.5","article-title":"Bench-to-bedside translation of magnetic nanoparticles","volume":"9","author":"Singh","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib109","doi-asserted-by":"crossref","first-page":"113503","DOI":"10.1039\/C6RA17217B","article-title":"An affinity triggered MRI nanoprobe for pH-dependent cell labeling","volume":"6","author":"Palma","year":"2016","journal-title":"RSC Adv"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","article-title":"Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme","volume":"103","author":"Maier-Hauff","year":"2011","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mser.2003.10.001","article-title":"Carbon nanotubes: properties and application","volume":"43","author":"Popov","year":"2004","journal-title":"Mater Sci Eng"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib112","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3390\/bioengineering4010003","article-title":"Ph-responsive mesoporous silica and carbon nanoparticles for drug delivery","volume":"4","author":"Gisbert-Garzar\u00e1n","year":"2017","journal-title":"Bioengineering (Basel)"},{"issue":"23","key":"10.1016\/B978-0-12-814029-1.00010-7_bib113","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/adma.200500477","article-title":"Single-walled carbon nanotube spectroscopy in live cells: towards long-term labels and optical sensors","volume":"17","author":"Heller","year":"2005","journal-title":"Adv Mater"},{"issue":"9","key":"10.1016\/B978-0-12-814029-1.00010-7_bib114","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nnano.2008.231","article-title":"Carbon nanotubes as photoacoustic molecular imaging agents in living mice","volume":"3","author":"De La Zerda","year":"2008","journal-title":"Nat Nanotechnol"},{"issue":"33","key":"10.1016\/B978-0-12-814029-1.00010-7_bib115","doi-asserted-by":"crossref","first-page":"11600","DOI":"10.1073\/pnas.0502680102","article-title":"Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction","volume":"102","author":"Shi Kam","year":"2005","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/B978-0-12-814029-1.00010-7_bib116","first-page":"2085","article-title":"Reversible accumulation of PEGylated single-walled carbon nanotubes in the mammalian nucleus","volume":"2","author":"Cheng","year":"2008","journal-title":"Am Chem Soc"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib117","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nnano.2011.151","article-title":"Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation","volume":"6","author":"Shi","year":"2011","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"10.1016\/B978-0-12-814029-1.00010-7_bib118","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nmat2766","article-title":"Filled and glycosylated carbon nanotubes for in\u00a0vivo radioemitter localization and imaging","volume":"9","author":"Hong","year":"2010","journal-title":"Nat Mater"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib119","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/nn700040t","article-title":"Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery","volume":"1","author":"Liu","year":"2007","journal-title":"ACS Nano"},{"issue":"37","key":"10.1016\/B978-0-12-814029-1.00010-7_bib120","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1039\/c1cc13011k","article-title":"Making carbon nanotubes biocompatible and biodegradable","volume":"47","author":"Bianco","year":"2011","journal-title":"Chem Commun"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib121","first-page":"71","article-title":"Cancer nanotheranostics: what have we learn so far?","volume":"3","author":"Conde","year":"2015","journal-title":"Front Chem"},{"issue":"12","key":"10.1016\/B978-0-12-814029-1.00010-7_bib122","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1021\/ar800035u","article-title":"Gold nanoparticles in biology: beyond toxicity to cellular imaging","volume":"41","author":"Murphy","year":"2008","journal-title":"Acc Chem Res"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib123","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fchem.2014.00048","article-title":"Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine","volume":"2","author":"Conde","year":"2014","journal-title":"Front Chem"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib124","first-page":"11","article-title":"Gold nanoparticle-based theranostics: disease diagnostics and treatment using a single nanomaterial","volume":"4","author":"Vinhas","year":"2015","journal-title":"Nanobiosensors Dis Diagnosis"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib125","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1039\/c0cs00180e","article-title":"Beating cancer in multiple ways using nanogold","volume":"40","author":"Dreaden","year":"2011","journal-title":"Chem Soc Rev"},{"issue":"10872","key":"10.1016\/B978-0-12-814029-1.00010-7_bib126","first-page":"1","article-title":"Photothermal enhancement of chemotherapy in breast cancer by visible irradiation of Gold Nanoparticles","volume":"7","author":"Mendes","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib127","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1039\/b806051g","article-title":"Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity","volume":"38","author":"Boisselier","year":"2009","journal-title":"Chem Soc Rev"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/smll.200700595","article-title":"Cytotoxicity of nanopartides","volume":"4","author":"Lewinski","year":"2008","journal-title":"Small"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib129","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1039\/C1CS15280G","article-title":"Gold nanoparticle-enabled biological and chemical detection and analysis","volume":"41","author":"Jans","year":"2012","journal-title":"Chem Soc Rev"},{"issue":"c","key":"10.1016\/B978-0-12-814029-1.00010-7_bib130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1039\/df9511100055","article-title":"A\u00a0study of the nucleation and growth process in the synthesis of colloidal gold","volume":"55","author":"Turkevich","year":"1951","journal-title":"Discuss Faraday Soc"},{"issue":"105","key":"10.1016\/B978-0-12-814029-1.00010-7_bib131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/physci241020a0","article-title":"Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions","volume":"241","author":"Frens","year":"1973","journal-title":"Nat Phys Sci"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib132","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"February","key":"10.1016\/B978-0-12-814029-1.00010-7_bib133","first-page":"1","article-title":"Surface engineering of nanoparticles for therapeutic applications","author":"Wei","year":"2014","journal-title":"Polym J"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib134","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2009.12.006","article-title":"The forthcoming applications of gold nanoparticles in drug and gene delivery systems","volume":"149","author":"Pissuwan","year":"2011","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.09.006","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"64","author":"Brigger","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib136","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1021\/nl803487r","article-title":"Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2\/KI etchant","volume":"9","author":"Cho","year":"2009","journal-title":"Nano Lett"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nnano.2008.30","article-title":"Nanoparticle-mediated cellular response is size-dependent","volume":"3","author":"Jiang","year":"2008","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib138","doi-asserted-by":"crossref","first-page":"14139","DOI":"10.1021\/ja805392f","article-title":"Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption\/ionization mass spectrometry","volume":"26","author":"Zhu","year":"2008","journal-title":"J\u00a0Am Chem Soc"},{"issue":"10","key":"10.1016\/B978-0-12-814029-1.00010-7_bib139","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1021\/nn900215k","article-title":"Multifunctional nanoparticles for\u00a0combined doxorubicin and photothermal treatments","volume":"3","author":"Park","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib140","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1158\/1078-0432.CCR-10-0978","article-title":"Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine","author":"Libutti","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib141","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2010.06.004","article-title":"Gold nanoparticle platforms as drug and biomacromolecule delivery systems","volume":"148","author":"Duncan","year":"2011","journal-title":"J\u00a0Control Release"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib142","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/aps.2011.82","article-title":"Gold nanoparticles in cancer therapy","volume":"32","author":"Lim","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib143","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/mp3005885","article-title":"Multifunctional gold nanoparticles for diagnosis and therapy of disease","volume":"10","author":"Mieszawska","year":"2013","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib144","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/mp060132k","article-title":"Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model","volume":"4","author":"Chen","year":"2007","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib145","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1021\/nn200007z","article-title":"Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells","volume":"5","author":"Wang","year":"2011","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib146","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/ja908117a","article-title":"Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin","volume":"132","author":"Brown","year":"2010","journal-title":"J\u00a0Am Chem Soc"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib147","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/jpet.301.1.77","article-title":"Novel glutathione-dependent thiopurine prodrugs: evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice","volume":"301","author":"Gunnarsdottir","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib148","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0891-5849(99)00275-0","article-title":"Redox state of glutathione in human plasma","volume":"28","author":"Jones","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib149","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/ja056726i","article-title":"Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers","volume":"128","author":"Hong","year":"2006","journal-title":"J\u00a0Am Chem Soc"},{"issue":"20","key":"10.1016\/B978-0-12-814029-1.00010-7_bib150","doi-asserted-by":"crossref","first-page":"203002","DOI":"10.1103\/PhysRevLett.89.203002","article-title":"Fluorescence quenching of dye molecules near gold nanoparticles: radiative and nonradiative effects","volume":"89","author":"Dulkeith","year":"2002","journal-title":"Phys Rev Lett"},{"issue":"6","key":"10.1016\/B978-0-12-814029-1.00010-7_bib151","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1083\/jcb.200910104","article-title":"Targeting of drugs and nanoparticles to tumors","volume":"188","author":"Ruoslahti","year":"2010","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib152","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/157339409788166733","article-title":"Cancer nanotechnology \u2013 prospects for cancer diagnostics and therapy","volume":"5","author":"Baptista","year":"2009","journal-title":"Curr Canc Ther Rev"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib153","first-page":"1","article-title":"Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events","author":"Conde","year":"2013","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib154","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/mp300016p","article-title":"Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in\u00a0vivo","volume":"9","author":"Done","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2014.03.045","article-title":"Antibody\u2013drug gold nanoantennas with Raman spectroscopic fingerprints for in\u00a0vivo tumour theranostics","volume":"183","author":"Conde","year":"2014","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib156","doi-asserted-by":"crossref","first-page":"295102","DOI":"10.1088\/0957-4484\/25\/29\/295102","article-title":"Biological characterization of cetuximab- conjugated gold nanoparticles in a tumor animal model","volume":"25","author":"Kao","year":"2014","journal-title":"Nanotechnology"},{"issue":"7490","key":"10.1016\/B978-0-12-814029-1.00010-7_bib157","first-page":"1","article-title":"Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles","volume":"4","author":"Qian","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib158","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/ie9011479","article-title":"Folate-receptor-targeted delivery of doxorubicin using polyethylene glycol-functionalized gold nanoparticles","volume":"49","author":"Asadishad","year":"2010","journal-title":"Ind Eng Chem Res"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib159","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2016.11.021","article-title":"Multifunctional gold-nanoparticles: a nanovectorization tool for the targeted delivery of novel chemotherapeutic agents","volume":"245","author":"Fernandes","year":"2017","journal-title":"J\u00a0Control Release"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.addr.2009.11.007","article-title":"Mukhopadhyay, Debabrata Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer","volume":"62","author":"Patra","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/B978-0-12-814029-1.00010-7_bib161","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/mp100207t","article-title":"Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer","volume":"7","author":"Chattopadhyay","year":"2010","journal-title":"Mol Pharm"},{"issue":"41","key":"10.1016\/B978-0-12-814029-1.00010-7_bib162","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1021\/ja9071282","article-title":"Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum (IV) warheads","volume":"131","author":"Dhar","year":"2009","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib163","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.2147\/IJN.S149306","article-title":"Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine","volume":"12","author":"Santiago","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.05.017","article-title":"Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy","volume":"100","author":"Chen","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.msec.2017.08.021","article-title":"Decoration of gold nanoparticles with thiolated pH-responsive polymeric (PEG-b-p(2-dimethylamio ethyl methacrylate-co-itaconic acid) shell: a novel platform for targeting of anticancer agent","volume":"81","author":"Ghorbani","year":"2017","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib166","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejmech.2017.08.063","article-title":"Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising in\u00a0vivo drug delivery system for colorectal cancer therapy","volume":"142","author":"Lee","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib167","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1080\/03639045.2017.1339082","article-title":"Gold nanoparticles capped with benzalkonium chloride and poly (ethylene imine) for enhanced loading and skin permeability of 5-fluorouracil","volume":"43","author":"Safwat","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib168","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/nano6030048","article-title":"Colloidal gold-mediated delivery of bleomycin for improved outcome in chemotherapy","volume":"6","author":"Yang","year":"2016","journal-title":"Nanomaterials"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-814029-1.00010-7_bib169","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2017.02.008","article-title":"Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting","volume":"520","author":"Ghorbani","year":"2017","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib170","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.3390\/genes8030094","article-title":"Gold nanoparticle approach to the selective delivery of gene silencing in cancer \u2013 the case for combined delivery?","volume":"8","author":"Mendes","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2003.09.013","article-title":"An overview of current delivery systems in cancer gene therapy","volume":"94","author":"El-aneed","year":"2004","journal-title":"J\u00a0Control Release"},{"issue":"9280","key":"10.1016\/B978-0-12-814029-1.00010-7_bib172","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(01)05629-X","article-title":"Antisense therapy in oncology: new hope for an old idea?","volume":"358","author":"Tamm","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib173","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1208\/aapsj070109","article-title":"DNA-based therapeutics and DNA delivery systems: a comprehensive review","volume":"7","author":"Patil","year":"2005","journal-title":"AAPS J"},{"issue":"20","key":"10.1016\/B978-0-12-814029-1.00010-7_bib174","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.biomaterials.2013.03.049","article-title":"Biomaterials cell penetration and cell-selective drug delivery using a -helix peptides conjugated with gold nanoparticles","volume":"34","author":"Park","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib175","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3390\/nano5041853","article-title":"Gold nanotheranostics: proof-of-concept or clinical tool","volume":"5","author":"Pedrosa","year":"2015","journal-title":"Nanomaterials"},{"issue":"7","key":"10.1016\/B978-0-12-814029-1.00010-7_bib176","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.nano.2012.02.001","article-title":"Stability of\u00a0antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy","volume":"8","author":"Raoof","year":"2012","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib177","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib178","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.omtn.2017.05.003","article-title":"Gold nanoparticles for BCR-ABL1 gene silencing: improving tyrosine kinase inhibitor efficacy in chronic myeloid leukemia","volume":"7","author":"Vinhas","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib179","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/nano7010010","article-title":"Gold nanobeacons for tracking gene silencing in zebrafish","volume":"7","author":"Cordeiro","year":"2017","journal-title":"Nanomaterials"},{"issue":"312","key":"10.1016\/B978-0-12-814029-1.00010-7_bib180","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1126\/science.1125559","article-title":"Oligonucleotide-modified gold nanoparticles for intracellular gene regulation","author":"Rosi","year":"2006","journal-title":"Science"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib181","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/1078-0432.CCR-08-1480","article-title":"Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog\u00a0\u2212 conjugated hollow gold nanospheres","volume":"15","author":"Lu","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/B978-0-12-814029-1.00010-7_bib182","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1039\/C6TB00710D","article-title":"Partially PEGylated dendrimer-entrapped gold nanoparticles: a promising nanoplatform for highly efficient DNA and siRNA delivery","volume":"4","author":"Hou","year":"2016","journal-title":"J\u00a0Mater Chem B"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib183","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.nano.2017.01.013","article-title":"Smuggling gold nanoparticles across cell types \u2013 a new role for exosomes in gene silencing","volume":"13","author":"Roma-Rodrigues","year":"2017","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/B978-0-12-814029-1.00010-7_bib184","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102029","article-title":"Targeted delivery of siRNA with pH-responsive hybrid gold nanostars for cancer treatment","volume":"18","author":"Zhu","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/B978-0-12-814029-1.00010-7_bib185","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2217\/nnm-2017-0081","article-title":"Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer","volume":"12","author":"Shahbazi","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib186","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bios.2012.04.006","article-title":"Gold-nanobeacons for real-time monitoring of RNA synthesis","volume":"36","author":"Rosa","year":"2012","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib187","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1021\/nn3030223","article-title":"Design of multifunctional gold nanoparticles for in\u00a0vitro and","volume":"6","author":"Conde","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib188","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/17435390.2013.802821","article-title":"Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis","volume":"8","author":"Conde","year":"2014","journal-title":"Nanotocicology"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib189","doi-asserted-by":"crossref","first-page":"505101","DOI":"10.1088\/0957-4484\/21\/50\/505101","article-title":"In\u00a0vitro transcription and translation inhibition via DNA functionalized gold nanoparticles","volume":"21","author":"Conde","year":"2010","journal-title":"Nanotechnology"},{"issue":"12","key":"10.1016\/B978-0-12-814029-1.00010-7_bib190","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1021\/nl072209h","article-title":"A\u00a0cellular Trojan horse for delivery of therapeutic nanoparticles into tumors","volume":"7","author":"Choi","year":"2007","journal-title":"Nano Lett"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib191","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10103-007-0470-x","article-title":"Plasmonic photothermal therapy (PPTT) using gold nanoparticles","volume":"23","author":"Huang","year":"2008","journal-title":"Lasers Med Sci"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib192","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2217\/17435889.2.1.125","article-title":"Hyperthermic effects of gold nanorods on tumor cells","volume":"2","author":"Huff","year":"2007","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib193","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jconrel.2011.10.028","article-title":"Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release","volume":"158","author":"You","year":"2012","journal-title":"J\u00a0Control Release"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib194","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1449","article-title":"Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment","volume":"9","author":"Riley","year":"2017","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12951-017-0321-2","article-title":"Potentiating angiogenesis arrest in\u00a0vivo via laser irradiation of peptide functionalised gold nanoparticles","volume":"15","author":"Pedrosa","year":"2017","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib196","first-page":"N309","article-title":"The use of gold nanoparticles to enhance radiotherapy","volume":"49","author":"Hainfeld","year":"2004","journal-title":"PhysMedBio"},{"issue":"29","key":"10.1016\/B978-0-12-814029-1.00010-7_bib197","doi-asserted-by":"crossref","first-page":"295101","DOI":"10.1088\/0957-4484\/21\/29\/295101","article-title":"Evaluation of cytotoxicity and radiation enhancement using 1.9\u00a0nm gold particles: potential application for cancer therapy","volume":"21","author":"Butterworth","year":"2010","journal-title":"Nanotechnology"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib198","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.addr.2010.08.004","article-title":"Imaging and drug delivery using theranostic nanoparticles","volume":"62","author":"Janib","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib199","first-page":"1","article-title":"Gold nanorods for target selective SPECT\/CT imaging and photothermal therapy in\u00a0vivo","volume":"2","author":"Jang","year":"2012","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib200","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1039\/c3nr05112a","article-title":"Emerging advances in nanomedicine with engineered gold nanostructures","volume":"6","author":"Webb","year":"2014","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib201","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cmmi.376","article-title":"A\u00a0fluorescent, paramagnetic and PEGylated gold\/silica nanoparticle for MRI, CT and fluorescence imaging","volume":"5","author":"van Schoonevelda","year":"2013","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib202","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1039\/C4NR04164J","article-title":"siRNA liposome-gold nanorod vectors for multispectral optoacoustic tomography theranostics","volume":"6","author":"Taruttis","year":"2014","journal-title":"Nanoscale"},{"issue":"6","key":"10.1016\/B978-0-12-814029-1.00010-7_bib203","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7150\/thno.8698","article-title":"Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics","volume":"4","author":"Muthu","year":"2014","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/B978-0-12-814029-1.00010-7_bib204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cmmi.1563","article-title":"Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermal therapy","volume":"9","author":"Curry","year":"2014","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib205","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.2147\/IJN.S140772","article-title":"Gold nanoparticles enlighten the future of cancer theranostics","volume":"12","author":"Guo","year":"2017","journal-title":"Int J Nanomed"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib206","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.biomaterials.2011.09.064","article-title":"Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy","volume":"33","author":"Heo","year":"2012","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/B978-0-12-814029-1.00010-7_bib207","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/nn901877h","article-title":"A\u00a0drug loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer","volume":"4","author":"Kim","year":"2010","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib208","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/thno.5409","article-title":"Gold nanorods based platforms for light-mediated theranostics","volume":"3","author":"Zhang","year":"2013","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib209","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7150\/thno.4756","article-title":"Gold nanorods conjugated with doxorubicin and cRGD for combined anti-cancer drug delivery and PET imaging","volume":"2","author":"Xiao","year":"2012","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/B978-0-12-814029-1.00010-7_bib210","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/adma.201104714","article-title":"Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment","volume":"24","author":"Zhang","year":"2012","journal-title":"Adv Mater"},{"issue":"10","key":"10.1016\/B978-0-12-814029-1.00010-7_bib211","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/ar200022e","article-title":"Cancer theranostics with near-infrared light-activatable multimodal nanoparticles","volume":"44","author":"Melancon","year":"2011","journal-title":"Acc Chem Res"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_bib212","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/nn901181c","article-title":"Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release","volume":"4","author":"You","year":"2010","journal-title":"ACS Nano"},{"issue":"31","key":"10.1016\/B978-0-12-814029-1.00010-7_bib213","doi-asserted-by":"crossref","first-page":"315701","DOI":"10.1088\/0957-4484\/26\/31\/315701","article-title":"Multifunctional magnetic-hollow gold nanospheres for bimodal cancer cell imaging and photothermal therapy","volume":"26","author":"Bai","year":"2015","journal-title":"Nanotechnology"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib214","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/nn406425h","article-title":"Fluorescent drug-loaded, polymeric-based, branched gold nanoshells for localized multimodal therapy and imaging of tumoral cells","volume":"8","author":"Topete","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib215","first-page":"1","article-title":"Cancer nanomedicine: from targeted delivery to combination therapy","author":"Xu","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib216","first-page":"695","article-title":"Combination chemotherapy in cancer: principles, evaluation and drug delivery strategies","author":"Pinto","year":"2010","journal-title":"Curr Cancer Treat"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib217","first-page":"1","article-title":"Drug resistance to targeted therapies: deja vu all over again","author":"Groenendijk","year":"2014","journal-title":"Mol Oncol"},{"issue":"23","key":"10.1016\/B978-0-12-814029-1.00010-7_bib218","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib219","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib220","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib221","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib222","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib223","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib224","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.04.007","article-title":"Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging","volume":"207","author":"Park","year":"2015","journal-title":"J\u00a0Control Release"},{"issue":"5","key":"10.1016\/B978-0-12-814029-1.00010-7_bib225","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1517\/17425240903571614","article-title":"Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery","volume":"7","author":"Cobley","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib226","first-page":"1","article-title":"PEGylated PAMAM dendrimer e doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib227","first-page":"1","article-title":"Near infrared light-actuated gold nanorods with cisplatin-polypeptide wrapping for targeted therapy of triple negative breast cancer","author":"Feng","year":"2015","journal-title":"R\u00a0Soc Chem"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib228","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/nl0500555","article-title":"Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy","volume":"6","author":"Everts","year":"2006","journal-title":"Nano Lett"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib229","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.addr.2015.12.018","article-title":"Synergistic nanomedicine by combined gene and photothermal therapy","volume":"98","author":"Kim","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib230","doi-asserted-by":"crossref","first-page":"E1278","DOI":"10.1073\/pnas.1421229112","article-title":"Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance","volume":"112","author":"Conde","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib231","first-page":"15","article-title":"Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model","author":"Conde","year":"2016","journal-title":"Nat Mater"},{"issue":"8","key":"10.1016\/B978-0-12-814029-1.00010-7_bib232","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7150\/thno.11335","article-title":"A\u00a0light-driven therapy of pancreatic adenocarcinoma using gold nanorods-based nanocarriers for co-delivery of doxorubicin and siRNA","volume":"5","author":"Yin","year":"2015","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/B978-0-12-814029-1.00010-7_bib233","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s11095-013-1180-7","article-title":"Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy","volume":"31","author":"You","year":"2014","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-814029-1.00010-7_bib234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.04.067","article-title":"Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy","volume":"470","author":"Monem","year":"2014","journal-title":"Int J Pharm"},{"issue":"61","key":"10.1016\/B978-0-12-814029-1.00010-7_bib235","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1039\/c2cc33543c","article-title":"pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells","volume":"48","author":"Shi","year":"2012","journal-title":"Chem Commun"},{"issue":"4","key":"10.1016\/B978-0-12-814029-1.00010-7_bib236","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/anie.201002820","article-title":"Multifunctional gold nanoshells on\u00a0silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity","volume":"50","author":"Liu","year":"2011","journal-title":"Angew Chem"},{"issue":"18","key":"10.1016\/B978-0-12-814029-1.00010-7_bib237","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1039\/C4NR03693J","article-title":"Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma","volume":"6","author":"Setua","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib238","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2741\/4161","article-title":"Nanoparticles as \u201csmart\u201d pharmaceutical delivery","volume":"18","author":"Chakraborty","year":"2013","journal-title":"Front Biosci"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib239","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib240","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib241","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib242","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib243","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"key":"10.1016\/B978-0-12-814029-1.00010-7_bib244","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2017"},{"issue":"2","key":"10.1016\/B978-0-12-814029-1.00010-7_fur1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4155\/tde.10.13","article-title":"Nanoparticle-assisted combination therapies for effective cancer treatment","volume":"1","author":"Hu","year":"2010","journal-title":"Ther Deliv"}],"container-title":["Applications of Targeted Nano Drugs and Delivery Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128140291000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128140291000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T22:46:38Z","timestamp":1662245198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128140291000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128140291"],"references-count":245,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-814029-1.00010-7","relation":{},"subject":[],"published":{"date-parts":[[2019]]}}}